Prediction of ROP Treatment and Evaluation of Screening Criteria in VLBW Infants-a Population Based Analysis
Roland Gerull1, Viviane Brauer2, Dirk Bassler3
1Department of Neonatology, University of Basel, Children's Hospital UKBB, 4056, Basel, Switzerland. roland.gerull@ukbb.ch.
Insights
Screening for retinopathy of prematurity (ROP) in preterm infants may be reduced. New criteria could potentially decrease screening by 13.2% while maintaining high sensitivity for ROP treatment.
Area of Science:
- Neonatal ophthalmology
- Perinatal medicine
- Public health
Background:
- Retinopathy of prematurity (ROP) incidence and screening guidelines vary globally.
- Current ROP screening protocols may not be optimized for local epidemiological data.
- Assessing ROP screening reduction based on incidence is crucial for resource allocation.
Purpose of the Study:
- To evaluate the potential for reducing ROP screening in preterm infants.
- To develop and validate a model for identifying infants requiring ROP treatment.
- To determine if ROP screening criteria can be refined based on local ROP incidence.
Main Methods:
- Observational cohort study of infants born before 32 weeks gestation in Switzerland (2006-2015).
- Analysis of chronological and postmenstrual ages at ROP treatment.
- Development and validation of a predictive model for ROP treatment using training (2006-2012) and validation (2013-2015) datasets.
Main Results:
- A total of 6719 preterm infants were analyzed after excluding early mortality.
- Screening before 60 days chronological or 37 3/7 weeks postmenstrual age identified all ROP treatment cases.
- A model achieved 95.0% sensitivity and 87.6% specificity, predicting a 13.2% reduction in screening.
- The model demonstrated good predictive accuracy (c-statistic = 0.916).
Conclusions:
- A significant reduction in infants requiring ROP screening appears feasible.
- Implementation of revised screening criteria requires prospective validation.
- Optimizing ROP screening protocols can improve efficiency and resource utilization.
Background:
The incidence of retinopathy of prematurity (ROP) and ROP screening criteria differ between countries. We assessed whether ROP screening could be reduced based on the local ROP incidence.
Methods:
Observational cohort study of infants born in Switzerland between 2006 and 2015 <32 0/7 weeks. Chronological and postmenstrual ages at ROP treatment were analyzed. A model to identify ROP treatment on patients born between 2006 and 2012 (training set) was developed and tested on patients born between 2013 and 2015 (validation set).
Results:
Of 7817 live-born infants, 1098 died within the first 5 weeks of life. The remaining 6719 infants were included into analysis. All patients requiring ROP treatment would have been identified if screening had been performed before reaching 60 days of life or 37 3/7 weeks postmenstrual age, whichever came first. The training and validation sets included 4522 and 2197 preterm infants encompassing 56 and 20 patients receiving ROP treatment, respectively. All patients would have required screening to reach 100% sensitivity. To reach a sensitivity of 95.0% and a specificity of 87.6%, we predicted a reduction in 13.2% of patients requiring screening (c-statistic = 0.916).
Conclusions:
A substantial reduction of infants requiring screening seems possible, but necessitates prospective testing of new screening criteria.
Related Concept Videos
Criteria for Causality: Bradford Hill Criteria - II
Criteria for Causality: Bradford Hill Criteria - I
Analysis of Population Pharmacokinetic Data
Predicting Molecular Geometry
Conservation of Small Populations
What is Population Genetics?


